{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T20:26:45Z","timestamp":1759177605049},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T00:00:00Z","timestamp":1504137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T00:00:00Z","timestamp":1504137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Glucose intolerance frequently develops in accordance with the progression of chronic liver disease. However, differences in the characteristics of glucose intolerance between patients with nonalcoholic fatty liver disease (NAFLD) and those with chronic hepatitis C (C-CH) remain incompletely understood. To clarify these differences, patients with NAFLD (n\u2009=\u200937) and C-CH (n\u2009=\u200940) were evaluated with a continuous glucose monitoring system (CGMS). In the patients with NAFLD, Maximum blood glucose concentration and blood glucose swings were significantly correlated with hepatic fibrosis markers. In the patients with C-CH, however, those two CGMS parameters were negatively correlated with the serum albumin (ALB) concentration. Furthermore, in the patients with C-CH with an ALB concentration of \u22644.0\u2009g\/dl, those two CGMS parameters were negatively correlated with the ALB concentration with greater statistical significance. In conclusion, obvious differences in the characteristics of glucose intolerance between patients with NAFLD and those with C-CH were clarified. In patients with NAFLD, glucose intolerance gradually progressed in accordance with the progression of hepatic fibrosis. In those with C-CH, glucose intolerance suddenly developed upon the appearance of hypoalbuminaemia.<\/jats:p>","DOI":"10.1038\/s41598-017-09256-4","type":"journal-article","created":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T09:46:01Z","timestamp":1503654361000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Differences in characteristics of glucose intolerance between patients with NAFLD and chronic hepatitis C as determined by CGMS"],"prefix":"10.1038","volume":"7","author":[{"given":"Tsunehiro","family":"Ochi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Nakahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhei","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Koshiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Munekage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eisuke","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Hiramatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsunari","family":"Ogasawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Mizuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosei","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuto","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narufumi","family":"Suganuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"Chayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuji","family":"Torimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiji","family":"Saibara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,31]]},"reference":[{"key":"9256_CR1","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","volume":"116","author":"CA Matteoni","year":"1999","unstructured":"Matteoni, C. A. et al. Nonalcoholic fatty liver diseases: a spectrum of clinical and pathological severity. Gastroenterology \n                           116, 1413\u20131419 (1999).","journal-title":"Gastroenterology"},{"key":"9256_CR2","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s00535-006-1876-0","volume":"41","author":"M Ono","year":"2006","unstructured":"Ono, M. & Saibara, T. Clinical features of nonalcoholic steatohepatitis in Japan: evidence from literature. J Gastroenterol. \n                           41, 725\u2013732 (2006).","journal-title":"J Gastroenterol."},{"key":"9256_CR3","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1002\/hep.25536","volume":"55","author":"SK Reddy","year":"2012","unstructured":"Reddy, S. K. et al. Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease. HEPATOLOGY \n                           55, 1809\u20131819 (2012).","journal-title":"HEPATOLOGY"},{"key":"9256_CR4","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1053\/jhep.2002.30692","volume":"35","author":"S Chitturi","year":"2002","unstructured":"Chitturi, S. et al. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. HEPATOLOGY \n                           35, 373\u2013379 (2002).","journal-title":"HEPATOLOGY"},{"key":"9256_CR5","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1053\/jhep.2003.50161","volume":"37","author":"G Marchesini","year":"2003","unstructured":"Marchesini, G. et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. HEPATOLOGY \n                           37, 917\u2013923 (2003).","journal-title":"HEPATOLOGY"},{"key":"9256_CR6","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1056\/NEJMra011775","volume":"18","author":"P Angulo","year":"2002","unstructured":"Angulo, P. Nonalcoholic fatty liver disease. N. Engl. J. Med. \n                           18, 1221\u20131231 (2002).","journal-title":"N. Engl. J. Med."},{"key":"9256_CR7","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/hep.23784","volume":"52","author":"BA Neuschwander-Tetri","year":"2010","unstructured":"Neuschwander-Tetri, B. A. et al. Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. HEPATOLOGY \n                           52, 913\u2013924 (2010).","journal-title":"HEPATOLOGY"},{"key":"9256_CR8","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/hep.22429","volume":"48","author":"AL Fracanzani","year":"2008","unstructured":"Fracanzani, A. L. et al. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. HEPATOLOGY \n                           48, 792\u2013798 (2008).","journal-title":"HEPATOLOGY"},{"key":"9256_CR9","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.cgh.2009.06.007","volume":"7","author":"N Hossain","year":"2009","unstructured":"Hossain, N. et al. Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. \n                           7, 1224\u20131229 (2009).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"9256_CR10","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1301\/nr.2007.jun.S57-S63","volume":"65","author":"P Angulo","year":"2007","unstructured":"Angulo, P. Obesity and nonalcoholic fatty liver disease. Nutr. Rev. \n                           65, S57\u201363 (2007).","journal-title":"Nutr. Rev."},{"key":"9256_CR11","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.510290235","volume":"29","author":"AL Mason","year":"1999","unstructured":"Mason, A. L. et al. Association of diabetes mellitus and chronic hepatitis C virus infection. HEPATOLOGY \n                           29, 328\u2013333 (1999).","journal-title":"HEPATOLOGY"},{"key":"9256_CR12","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/hep.22703","volume":"49","author":"Y Arase","year":"2009","unstructured":"Arase, Y. et al. Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C. HEPATOLOGY \n                           49, 739\u2013744 (2009).","journal-title":"HEPATOLOGY"},{"key":"9256_CR13","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1053\/j.gastro.2003.10.065","volume":"126","author":"HB El-Serag","year":"2004","unstructured":"El-Serag, H. B., Tran, T. & Everhart, J. E. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology \n                           126, 460\u2013468 (2004).","journal-title":"Gastroenterology"},{"key":"9256_CR14","doi-asserted-by":"publisher","first-page":"756","DOI":"10.2337\/diacare.22.5.756","volume":"22","author":"R De Marco","year":"1999","unstructured":"De Marco, R. et al. Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study. Diabetes Care \n                           22, 756\u2013761 (1999).","journal-title":"Diabetes Care"},{"key":"9256_CR15","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/0895-4356(91)90209-R","volume":"44","author":"B Balkau","year":"1991","unstructured":"Balkau, B., Eschw\u00e8ge, E., Ducimeti\u00e8re, P., Richard, J. L. & Warnet, J. M. The high risk of death by alcohol related diseases in subjects diagnosed as diabetic and impaired glucose tolerant: the Paris Prospective Study after 15 years of follow-up. J Clin Epidemiol. \n                           44, 465\u2013474 (1991).","journal-title":"J Clin Epidemiol."},{"key":"9256_CR16","first-page":"2","volume":"2","author":"AS Petrides","year":"1994","unstructured":"Petrides, A. S. Liver disease and diabetes mellitus. Diabetes Rev \n                           2, 2\u201318 (1994).","journal-title":"Diabetes Rev"},{"key":"9256_CR17","first-page":"119","volume":"20","author":"G Bianchi","year":"1994","unstructured":"Bianchi, G. et al. Prognostic significance of diabetes in patients with cirrhosis. HEPATOLOGY \n                           20, 119\u2013425 (1994).","journal-title":"HEPATOLOGY"},{"key":"9256_CR18","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.2337\/diacare.28.5.1231","volume":"28","author":"DC Klonoff","year":"2005","unstructured":"Klonoff, D. C. Continuous glucose monitoring: roadmap for 21st century diabetes therapy. Diabetes Care \n                           28, 1231\u20131239 (2005).","journal-title":"Diabetes Care"},{"key":"9256_CR19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/j.1464-5491.2009.02684.x","volume":"26","author":"P Bialasiewicz","year":"2009","unstructured":"Bialasiewicz, P., Pawlowski, M., Nowak, D., Loba, J. & Czupryniak, L. Decreasing concentration of interstitial glucose in REM sleep in subjects with normal glucose tolerance. Diabetic Medicine \n                           26, 339\u2013344 (2009).","journal-title":"Diabetic Medicine"},{"key":"9256_CR20","first-page":"103","volume":"58","author":"T Kawaguchi","year":"2011","unstructured":"Kawaguchi, T. et al. Serum level of free fatty acids is associated with nocturnal hypoglycemia in cirrhotic patients with HCV infection: a pilot study. Hepato-gastroenterology \n                           58, 103\u2013108 (2011).","journal-title":"Hepato-gastroenterology"},{"key":"9256_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076161","volume":"8","author":"H Motoi","year":"2013","unstructured":"Motoi, H. et al. Glycemic Variability is an Independent Predictive Factor for Development of Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease. PLoS One \n                           8, e76161 (2013).","journal-title":"PLoS One"},{"key":"9256_CR22","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.2337\/db08-0063","volume":"57","author":"A Ceriello","year":"2008","unstructured":"Ceriello, A. et al. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes \n                           57, 1349\u20131354 (2008).","journal-title":"Diabetes"},{"key":"9256_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-8-23","volume":"8","author":"K Node","year":"2009","unstructured":"Node, K. & Inoue, T. Postprandial hyperglycemia as an etiological factor in vascular failure. Cardiovasc Diabetol. \n                           8, 23 (2009).","journal-title":"Cardiovasc Diabetol."},{"key":"9256_CR24","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1001\/jama.295.14.1681","volume":"295","author":"L Monnier","year":"2006","unstructured":"Monnier, L. et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA \n                           295, 1681\u20131687 (2006).","journal-title":"JAMA"},{"key":"9256_CR25","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1002\/hep.21638","volume":"45","author":"A Hirose","year":"2007","unstructured":"Hirose, A. et al. Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis. HEPATOLOGY \n                           45, 1375\u20131381 (2007).","journal-title":"HEPATOLOGY"},{"key":"9256_CR26","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00535-012-0527-x","volume":"47","author":"H Fujii","year":"2012","unstructured":"Fujii, H. & Kawada, N. Inflammation and fibrogenesis in steatohepatitis. J Gastroenterol. \n                           47, 215\u2013225 (2012).","journal-title":"J Gastroenterol."},{"key":"9256_CR27","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/j.1872-034X.2011.00957.x","volume":"42","author":"N Matsumoto","year":"2012","unstructured":"Matsumoto, N. et al. Prevalence and predictive factors of diabetes in hepatitis virus positive liver cirrhosis with fasting plasmaglucose level of <126\u2009mg\/dl. Hepatol Res. \n                           42, 558\u2013563 (2012).","journal-title":"Hepatol Res."},{"key":"9256_CR28","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1007\/s00535-011-0436-4","volume":"46","author":"M Yoneda","year":"2011","unstructured":"Yoneda, M. et al. Japan Study Group of Nonalcoholic Fatty Liver Disease. Platelet count for predicting fibrosis in nonalcoholic fatty liver disease. J Gastroenterol \n                           46, 1300\u20131306 (2011).","journal-title":"J Gastroenterol"},{"key":"9256_CR29","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1665-2681(19)31588-1","volume":"10","author":"JO Quintana","year":"2011","unstructured":"Quintana, J. O. et al. The impact of diabetes mellitus in mortality of patients with compensated liver cirrhosis-a prospective study. Ann Hepatol. \n                           10, 56\u201362 (2011).","journal-title":"Ann Hepatol."},{"key":"9256_CR30","doi-asserted-by":"crossref","first-page":"491","DOI":"10.5694\/j.1326-5377.1975.tb111524.x","volume":"1","author":"DJ Whalan","year":"1975","unstructured":"Whalan, D. J. The ethics and morality of clinical trials in man. Med. J. Aust. \n                           1, 491\u2013494 (1975).","journal-title":"Med. J. Aust."},{"key":"9256_CR31","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/hep.21334","volume":"44","author":"A Vallet-Pichard","year":"2006","unstructured":"Vallet-Pichard, A., Mallet, V. & Pol, S. FIB-4: a simple, inexpensive and accurate marker of fibrosis in HCV-infected patients. HEPATOLOGY \n                           44, 769\u2013770 (2006).","journal-title":"HEPATOLOGY"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09256-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09256-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09256-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T09:52:58Z","timestamp":1671789178000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09256-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,31]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["9256"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-09256-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,31]]},"assertion":[{"value":"2 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"10146"}}